# Short Course Radiation Therapy Followed by Pre-operative Chemotherapy and Surgery in High-risk Rectal Cancer

> **NCT03729687** · PHASE2 · UNKNOWN · sponsor: **Uppsala University** · enrollment: 280 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **COMBINATION_PRODUCT:** radiotherapy, capecitabine, oxaliplatin

## Key facts

- **NCT ID:** NCT03729687
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07-04
- **Primary completion:** 2020-05-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2023-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03729687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03729687, "Short Course Radiation Therapy Followed by Pre-operative Chemotherapy and Surgery in High-risk Rectal Cancer". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT03729687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*